We came across a bullish thesis on Verona Pharma plc (VRNA) on Capital Employed’s Substack by Patients Capital Management. In this article, we will summarize the bulls’ thesis on VRNA. Verona Pharma plc (VRNA)'s share was trading at $91.53 as of 3rd July.
[caption id="attachment_1205577" align="aligncenter" width="768"]Verona Pharma, a UK-based biopharmaceutical company, is advancing a standout therapeutic with its lead asset, Ohtuvayre, poised to redefine treatment for...
Create a free account, or log in to read the full article
No credit card required.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.